BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2012
View Archived Issues
Abbott presents new serotonin 5-HT6 receptor modulators
Read More
Co-clinical study method identifies mutations limiting lung cancer treatment efficacy
Read More
Tyrosine-protein kinase SYK inhibitor has beneficial effects on asthma
Read More
Preliminary phase I results presented on AZD-2014
Read More
Olodaterol shows efficacy in asthma trials
Read More
Clinical data show long-term effects of lebrikizumab and the role of periostin
Read More
Novel GPR17 receptor modulators reported by Italian group
Read More
Theravance discloses novel candidate hepatitis C therapies
Read More
GlaxoSmithKline discovers new LDH-A inhibitors
Read More
Novel treatments for IBD prepared by Spanish team
Read More
Researchers at Marine Polymer Technologies patent new potential melanoma vaccines
Read More
Astellas and Drais partner on another IBS drug candidate
Read More
OTSA-101 receives E.U. orphan drug status
Read More
GE Healthcare and Affibody collaborate on HER2-specific PET imaging agent
Read More
Baxter and Chatham enter collaboration on hemophilia B gene therapy development
Read More
Takeda expands its position in gout market
Read More
First-in-human data presented on novel selective Notch pathway inhibitor
Read More
AFFiRiS launches first-ever clinical study of vaccine candidate for Parkinson's disease
Read More
Cleveland BioLabs reports survival results with CBLB-502
Read More
Emergent BioSolutions obtains BARDA funding for BioThrax
Read More
Evotec/Boehringer Ingelheim alliance reaches milestone
Read More
ThromboGenics and BioInvent to regain global rights to PlGF-directed mAb
Read More
Phase IIb data on anticoagulant lead to decision to stop its development
Read More
Genmab and Novartis enter bispecific antibody collaboration
Read More
Dainippon Sumitomo Pharma and Shionogi to copromote combination hypertension drug in Japan
Read More
Janssen files NDA for canagliflozin
Read More
Astellas and Ambit begin phase IIb quizartinib monotherapy study in relapsed/refractory AML
Read More